19 research outputs found
Patient characteristics at ART initiation and treatment outcomes for patients initiating a tenofovir based regimen at the Themba Lethu Clinic in Johannesburg, South Africa.
*<p>Among patients with at least 1 viral load between 1 month and 1 year after ART initiation.</p>+<p>Among patients with at least 1 viral load after 4 months on treatment.</p
Unadjusted and adjusted predictors of attrition, virologic suppression, and treatment failure among patients initiated on a tenofovir-based ART regimen between April 2010 and June 2011 at the Themba Lethu Clinic in Johannesburg, South Africa.
<p>Unadjusted and adjusted predictors of attrition, virologic suppression, and treatment failure among patients initiated on a tenofovir-based ART regimen between April 2010 and June 2011 at the Themba Lethu Clinic in Johannesburg, South Africa.</p
South African National Department of Health policy on eligibility for decentralized drug-resistant TB care.
<p>South African National Department of Health policy on eligibility for decentralized drug-resistant TB care.</p
Relative risk<sup>*</sup> and 95% confidence intervals of dying or being lost from treatment.
<p>Relative risk<sup><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0164974#t005fn001" target="_blank">*</a></sup> and 95% confidence intervals of dying or being lost from treatment.</p
TB disease of RR-TB patients at enrolment<sup>^</sup>, laboratory results.
<p>TB disease of RR-TB patients at enrolment<sup><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0164974#t003fn001" target="_blank">^</a></sup>, laboratory results.</p
Descriptive characteristics at initiation of second-line TB treatment of RR-TB patients.
<p>Descriptive characteristics at initiation of second-line TB treatment of RR-TB patients.</p
Demographic and clinical characteristics of patients who had a diagnosis of laboratory-confirmed RR-TB reported to the COJ for tracing between July 2011 and June 2012 (n = 594).
<p>Demographic and clinical characteristics of patients who had a diagnosis of laboratory-confirmed RR-TB reported to the COJ for tracing between July 2011 and June 2012 (n = 594).</p
Comparison of case characteristics between those initiated treatment at outpatient and inpatient sites (n = 256).
<p>Comparison of case characteristics between those initiated treatment at outpatient and inpatient sites (n = 256).</p